Review Articles

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

Myeloma Unit, Division of Hematology, University of Torino, Azienda-Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Italy
Universitätsklinikum Freiburg, Medical Department, Hematology, Oncology & Stem Cell Transplantation, Freiburg, Germany
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Greece
Universitätsklinikum Freiburg, Medical Department, Hematology, Oncology & Stem Cell Transplantation, Freiburg, Germany
Department of Oncology, A.O.U Città della Salute e della Scienza di Torino, and Department of Molecular Biotechnology and Health Sciences, University of Torino, Italy
Centre for Haematology, Department of Medicine, Imperial College London, UK
Department of Clinical Hematology, Centre Hospitalier Universitaire de Liège, Domaine Universitaire du Sart Tilman, Liège, Belgium
Division of Stem Cell Transplantation and Immunotherapy, 2nd Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Myeloma Unit, Division of Hematology, University of Torino, Azienda-Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Italy
Seragnoli Institute of Hematology, Bologna University School of Medicine, Italy
INSERM, UMR_S 938, Proliferation and Differentiation of Stem Cells, Paris, AP-HP, Hôpital Saint Antoine, Département d’Hématologie et de Thérapie Cellulaire; Sorbonne Universités, UPMC Univ Paris 06, France
Tumorzentrum München, Germany
Department of Hematooncology, University Hospital Ostrava, Czech Republic and Faculty of Medicine University of Ostrava, Czech Republic
Wilhelminen Cancer Research Institute, c/o Department of Medicine I, Center of Oncology, Hematology and Palliative Care, Vienna, Austria
Department of Internal Medicine II, University Hospital Würzburg, Germany
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Greece
Myeloma Unit, Division of Hematology, University of Torino, Azienda-Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Italy
Department of Stem cell Transplantation, University Medical Center Hamburg-Eppendorf, Germany
Seragnoli Institute of Hematology, Bologna University School of Medicine, Italy
Medizinische Klinik, Abteilung Innere Medizin V, Universitätsklinikum Heidelberg und National Centrum für Tumorerkrankungen (NCT), Heidelberg, Germany
Department of Oncology, A.O.U Città della Salute e della Scienza di Torino, and Department of Molecular Biotechnology and Health Sciences, University of Torino, Italy
Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands
Vol. 103 No. 2 (2018): February, 2018 https://doi.org/10.3324/haematol.2017.174573